Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 7, Pages 744
Publisher
MDPI AG
Online
2021-07-06
DOI
10.3390/vaccines9070744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
- (2021) Konlavat Siriwattananon et al. Frontiers in Plant Science
- Plant molecular farming for the production of valuable proteins – Critical evaluation of achievements and future challenges
- (2021) Stefan Schillberg et al. JOURNAL OF PLANT PHYSIOLOGY
- Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
- (2021) Konlavat Siriwattananon et al. Frontiers in Plant Science
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
- (2020) Balamurugan Shanmugaraj et al. Pathogens
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Potential Applications of Plant Biotechnology against SARS-CoV-2
- (2020) Teresa Capell et al. TRENDS IN PLANT SCIENCE
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
- (2020) Sabari Nath Neerukonda et al. Pathogens
- COVID-19 pathophysiology: A review
- (2020) Koichi Yuki et al. CLINICAL IMMUNOLOGY
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- COVID-19 Vaccine: A comprehensive status report
- (2020) Simran Preet Kaur et al. VIRUS RESEARCH
- Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
- (2020) Balamurugan Shanmugaraj et al. Plants-Basel
- Genetic and pathogenic characterization of SARS-CoV-2: a review
- (2020) Afsane Bahrami et al. Future Virology
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
- (2020) Mimi Guebre-Xabier et al. VACCINE
- Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
- (2020) Kaewta Rattanapisit et al. Scientific Reports
- SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
- (2020) Mei-Yue Wang et al. Frontiers in Cellular and Infection Microbiology
- Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities
- (2020) Borja Diego-Martin et al. Frontiers in Plant Science
- Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
- (2020) Balamurugan Shanmugaraj et al. Frontiers in Plant Science
- COVID-19: Coronavirus Vaccine Development Updates
- (2020) Jing Zhao et al. Frontiers in Immunology
- COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
- (2020) Kajal Rawat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Selection of adjuvants for vaccines targeting specific pathogens
- (2019) Indranil Sarkar et al. Expert Review of Vaccines
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Adjuvants for Animal Vaccines
- (2018) Yulia Burakova et al. VIRAL IMMUNOLOGY
- Immunology and efficacy of MF59-adjuvanted vaccines
- (2018) Eun-Ju Ko et al. Human Vaccines & Immunotherapeutics
- TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles
- (2018) Mojca Frank-Bertoncelj et al. Frontiers in Immunology
- Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
- (2018) Nataschja I. Ho et al. Frontiers in Immunology
- Production of virus-like particles for vaccines
- (2017) J. Fuenmayor et al. New Biotechnology
- Modes of Action for Mucosal Vaccine Adjuvants
- (2017) Taiki Aoshi VIRAL IMMUNOLOGY
- Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
- (2017) Kai Ling Chin et al. Journal of Immunology Research
- CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1
- (2016) Nerissa Lakhan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity
- (2016) Indranil Sarkar et al. VACCINE
- From discovery to licensure, the Adjuvant System story
- (2016) Nathalie Garçon et al. Human Vaccines & Immunotherapeutics
- Recent advances in the production of recombinant subunit vaccines inPichia pastoris
- (2016) Man Wang et al. Bioengineered
- Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
- (2015) Naru Zhang et al. Cellular & Molecular Immunology
- Plant-made oral vaccines against human infectious diseases-Are we there yet?
- (2015) Hui-Ting Chan et al. PLANT BIOTECHNOLOGY JOURNAL
- Plant Molecular Pharming for the Treatment of Chronic and Infectious Diseases
- (2014) Eva Stoger et al. Annual Review of Plant Biology
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- Current advancements and potential strategies in the development of MERS-CoV vaccines
- (2014) Naru Zhang et al. Expert Review of Vaccines
- Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?
- (2014) Roslyn M. Bill JOURNAL OF PHARMACY AND PHARMACOLOGY
- Plant-based vaccines against viruses
- (2014) Edward P Rybicki Virology Journal
- Playing catch-up with Escherichia coli: using yeast to increase success rates in recombinant protein production experiments
- (2014) Roslyn M. Bill Frontiers in Microbiology
- TLR3 agonists and proinflammatory antitumor activities
- (2013) Sherven Sharma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Enhancing immunogenicity of a 3′aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates
- (2013) Michael J. McCluskie et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
- (2013) Harshad P. Patil et al. JOURNAL OF CONTROLLED RELEASE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells
- (2012) Yong-Gang Li et al. Virology Journal
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Vaccine adjuvants – Current status and prospects on controlled release adjuvancity
- (2011) S.M. Sivakumar et al. SAUDI PHARMACEUTICAL JOURNAL
- Mode of action of adjuvants: Implications for vaccine safety and design
- (2010) Béatris Mastelic et al. BIOLOGICALS
- New adjuvants for human vaccines
- (2010) M Lamine Mbow et al. CURRENT OPINION IN IMMUNOLOGY
- A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets
- (2010) R. Bodewes et al. JOURNAL OF VIROLOGY
- Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus
- (2010) Y. Hofmeister et al. JOURNAL OF VIROLOGY
- The immunobiology of aluminium adjuvants: how do they really work?
- (2010) Christopher Exley et al. TRENDS IN IMMUNOLOGY
- Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A
- (2009) Caglar Cekic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant
- (2009) M. Paula Longhi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started